Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Intra-Cellular Therapies Profit Margin 2013-2020 | ITCI

Current and historical gross margin, operating margin and net profit margin for Intra-Cellular Therapies (ITCI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Intra-Cellular Therapies net profit margin as of June 30, 2020 is 0%.
  
Intra-Cellular Therapies Annual Profit Margins
Intra-Cellular Therapies Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.617B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.910B 10.23
Amgen (AMGN) United States $130.879B 14.22
CSL (CSLLY) Australia $94.333B 0.00
Gilead Sciences (GILD) United States $75.236B 10.83
Regeneron Pharmaceuticals (REGN) United States $61.976B 23.70
Vertex Pharmaceuticals (VRTX) United States $55.269B 30.84
Illumina (ILMN) United States $46.974B 54.63
Biogen (BIIB) United States $39.286B 6.98
Seattle Genetics (SGEN) United States $34.263B 0.00
Moderna (MRNA) United States $27.885B 0.00
BeiGene (BGNE) Cayman Islands $27.328B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.301B 10.96
Genmab (GMAB) Denmark $22.905B 14.45
Genmab (GNMSF) Denmark $21.446B 4.94
Exact Sciences (EXAS) United States $19.690B 0.00
Incyte (INCY) United States $19.322B 0.00
BioNTech SE (BNTX) Germany $18.995B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Horizon Therapeutics Public (HZNP) Ireland $16.135B 37.75
Alnylam Pharmaceuticals (ALNY) United States $14.707B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.815B 100.24
ARGENX SE-ADR (ARGX) Netherlands $12.167B 0.00
MyoKardia (MYOK) United States $11.815B 0.00
QIAGEN (QGEN) Netherlands $11.388B 25.64
Guardant Health (GH) United States $11.105B 0.00
Sarepta Therapeutics (SRPT) United States $10.961B 0.00
Bio-Techne Corp (TECH) United States $10.264B 70.42
Mirati Therapeutics (MRTX) United States $9.316B 0.00
Repligen (RGEN) United States $9.232B 146.53
Ascendis Pharma (ASND) Denmark $8.679B 0.00
Galapagos (GLPG) Belgium $8.365B 30.26
ACADIA Pharmaceuticals (ACAD) United States $7.310B 0.00
Adaptive Biotechnologies (ADPT) United States $6.955B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.885B 213.30
Exelixis (EXEL) United States $6.690B 24.33
Acceleron Pharma (XLRN) United States $6.496B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.904B 0.00
Blueprint Medicines (BPMC) United States $5.809B 0.00
Novavax (NVAX) United States $5.490B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.454B 14.90
Arena Pharmaceuticals (ARNA) United States $5.023B 0.00
Emergent Biosolutions (EBS) United States $5.022B 19.89
Amicus Therapeutics (FOLD) United States $4.899B 0.00
Denali Therapeutics (DNLI) United States $4.863B 0.00
China Biologic Products (CBPO) China $4.575B 27.15
NeoGenomics (NEO) United States $4.555B 1375.00
Vir Biotechnology (VIR) United States $4.514B 0.00
Fate Therapeutics (FATE) United States $4.122B 0.00
Halozyme Therapeutics (HALO) United States $4.082B 0.00
Reata Pharmaceuticals (RETA) United States $4.001B 0.00
Twist Bioscience (TWST) United States $3.733B 0.00
Insmed (INSM) United States $3.676B 0.00
Legend Biotech (LEGN) United States $3.605B 0.00
Bluebird Bio (BLUE) United States $3.558B 0.00
Global Blood Therapeutics (GBT) United States $3.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.439B 0.00
MorphoSys AG (MOR) Germany $3.381B 44.31
Eidos Therapeutics (EIDX) United States $2.830B 0.00
Alkermes (ALKS) Ireland $2.530B 53.03
PHARMA MAR SA (PHMMF) Spain $2.396B 0.00
I-Mab (IMAB) China $2.349B 0.00
Seres Therapeutics (MCRB) United States $2.304B 0.00
Editas Medicine (EDIT) United States $2.024B 0.00
Sorrento Therapeutics (SRNE) United States $2.018B 0.00
Beam Therapeutics (BEAM) United States $1.980B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.968B 0.00
Amarin (AMRN) Ireland $1.889B 0.00
Zymeworks (ZYME) Canada $1.885B 0.00
UniQure (QURE) Netherlands $1.875B 0.00
Inovio Pharmaceuticals (INO) United States $1.861B 0.00
Viela Bio (VIE) United States $1.822B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Revance Therapeutics (RVNC) United States $1.716B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.581B 0.00
Sangamo Therapeutics (SGMO) United States $1.578B 0.00
Intellia Therapeutics (NTLA) United States $1.494B 0.00
Zealand Pharma (ZEAL) Denmark $1.435B 0.00
Ligand Pharmaceuticals (LGND) United States $1.386B 46.84
Arcus Biosciences (RCUS) United States $1.346B 0.00
Epizyme (EPZM) United States $1.315B 0.00
Alcobra (ARCT) United States $1.287B 0.00
Mersana Therapeutics (MRSN) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.274B 7.43
Mesoblast (MESO) Australia $1.265B 0.00
Zealand Pharma (ZLDPF) Denmark $1.264B 0.00
NGM Biopharmaceuticals (NGM) United States $1.200B 0.00
Cytokineticsorporated (CYTK) United States $1.151B 0.00
REGENXBIO (RGNX) United States $1.111B 0.00
Retrophin (RTRX) United States $1.095B 0.00
Myriad Genetics (MYGN) United States $1.079B 0.00
Heska (HSKA) United States $1.060B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.043B 0.00
Genetron Holdings (GTH) China $1.029B 0.00
Castle Biosciences (CSTL) United States $1.009B 0.00
Adverum Biotechnologies (ADVM) United States $0.982B 0.00
Compugen (CGEN) Israel $0.957B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.954B 0.00
Athenex (ATNX) United States $0.930B 0.00
Vericel (VCEL) United States $0.920B 0.00
Northwest Biotherapeutics (NWBO) United States $0.909B 0.00
NantKwest (NK) United States $0.902B 0.00
Scholar Rock Holding (SRRK) United States $0.897B 0.00
Codexis (CDXS) United States $0.851B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.841B 0.00
Morphic Holding (MORF) United States $0.822B 0.00
Arvinas (ARVN) United States $0.806B 0.00
Alector (ALEC) United States $0.789B 0.00
Pliant Therapeutics (PLRX) United States $0.785B 0.00
Intrexon (PGEN) United States $0.767B 0.00
AnaptysBio (ANAB) United States $0.763B 0.00
Frequency Therapeutics (FREQ) United States $0.756B 0.00
Protagonist Therapeutics (PTGX) United States $0.746B 0.00
Cellectis S.A (CLLS) France $0.741B 0.00
Agenus (AGEN) United States $0.704B 0.00
Pharming Group (PHGUF) Netherlands $0.688B 15.71
Syndax Pharmaceuticals (SNDX) United States $0.688B 0.00
MiMedx (MDXG) United States $0.648B 0.00
Cara Therapeutics (CARA) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.622B 0.00
Celldex Therapeutics (CLDX) United States $0.620B 0.00
Kadmon Holdings (KDMN) United States $0.596B 0.00
VBI Vaccines (VBIV) United States $0.580B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.579B 5.07
Geron (GERN) United States $0.574B 0.00
IVERIC Bio (ISEE) United States $0.558B 0.00
Cel-Sci (CVM) United States $0.516B 0.00
MeiraGTx Holdings (MGTX) United States $0.510B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.493B 0.00
Albireo Pharma (ALBO) United States $0.489B 0.00
Anika Therapeutics (ANIK) United States $0.489B 21.37
AMAG Pharmaceuticals (AMAG) United States $0.473B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.472B 0.00
UROGEN PHARMA (URGN) United States $0.472B 0.00
Clovis Oncology (CLVS) United States $0.466B 0.00
Prothena (PRTA) Ireland $0.459B 0.00
MannKind (MNKD) United States $0.458B 0.00
Sutro Biopharma (STRO) United States $0.455B 0.00
Avid Bioservices (CDMO) United States $0.443B 0.00
Amryt Pharma (AMYT) United Kingdom $0.441B 0.00
Dynavax Technologies (DVAX) United States $0.424B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.417B 0.00
Starpharma Holdings (SPHRY) Australia $0.411B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Forte Biosciences (FBRX) United States $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.377B 0.00
Cardiff Oncology (CRDF) United States $0.358B 0.00
Cue Biopharma (CUE) United States $0.356B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
AC Immune SA (ACIU) Switzerland $0.354B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.352B 0.00
Kala Pharmaceuticals (KALA) United States $0.352B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.350B 0.00
Spero Therapeutics (SPRO) United States $0.349B 0.00
IBio (IBIO) United States $0.346B 0.00
ANI Pharmaceuticals (ANIP) United States $0.342B 8.08
Kamada (KMDA) Israel $0.339B 16.21
Precision BioSciences (DTIL) United States $0.338B 0.00
Trevena (TRVN) United States $0.334B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.333B 0.00
Innate Pharma S.A (IPHA) France $0.329B 0.00
BioDelivery Sciences (BDSI) United States $0.327B 23.14
Syros Pharmaceuticals (SYRS) United States $0.320B 0.00
Athersys (ATHX) United States $0.320B 0.00
Selecta Biosciences (SELB) United States $0.317B 0.00
CytomX Therapeutics (CTMX) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.287B 0.00
WAVE Life Sciences (WVE) Singapore $0.287B 0.00
NextCure (NXTC) United States $0.284B 0.00
XOMA (XOMA) United States $0.263B 0.00
PDL BioPharma (PDLI) United States $0.254B 0.00
Affimed (AFMD) Germany $0.252B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Arbutus Biopharma (ABUS) United States $0.234B 0.00
TELA Bio (TELA) United States $0.233B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.218B 0.00
Fortress Biotech (FBIO) United States $0.214B 0.00
Dyadic (DYAI) United States $0.211B 0.00
Verastem (VSTM) United States $0.210B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
Eton Pharmaceuticals (ETON) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
ADMA Biologics Inc (ADMA) United States $0.184B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.169B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
Biofrontera AG (BFRA) Germany $0.160B 0.00
DBV Technologies S.A (DBVT) France $0.159B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
Kindred Biosciences (KIN) United States $0.155B 0.00
Bellus Health (BLU) Canada $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.147B 0.00
Checkpoint Therapeutics (CKPT) United States $0.146B 0.00
GENFIT S.A (GNFT) France $0.145B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.141B 6.60
Aptinyx (APTX) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Exicure (XCUR) United States $0.138B 0.00
Unum Therapeutics (COGT) United States $0.136B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
SESEN BIO, INC (SESN) United States $0.130B 0.00
AquaBounty Technologies (AQB) United States $0.129B 0.00
Cidara Therapeutics (CDTX) United States $0.125B 0.00
Aytu Bioscience (AYTU) United States $0.124B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Strongbridge Biopharma (SBBP) United States $0.108B 0.00
Celyad SA (CYAD) Belgium $0.105B 0.00
Orgenesis (ORGS) United States $0.103B 5.26
Abeona Therapeutics (ABEO) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Enzo Biochem (ENZ) United States $0.092B 0.00
Idera Pharmaceuticals (IDRA) United States $0.090B 0.00
Palatin Technologies (PTN) United States $0.090B 0.00
Cyclerion Therapeutics (CYCN) United States $0.085B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.084B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
Evogene (EVGN) Israel $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Stealth BioTherapeutics (MITO) United States $0.079B 75.81
Bionano Genomics (BNGO) United States $0.073B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Appili Therapeutics (APLIF) Canada $0.061B 0.00
AmpliPhi Biosciences (ARMP) United States $0.059B 0.00
Edesa Biotech (EDSA) Canada $0.058B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Novogen (KZIA) Australia $0.042B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
Vaccinex (VCNX) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Cleveland BioLabs (CBLI) United States $0.035B 0.00
Apricus Biosciences (SEEL) United States $0.035B 0.00
ATyr Pharma (LIFE) United States $0.032B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
OvaScience (MLND) United States $0.029B 0.00
Advaxis (ADXS) United States $0.026B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Titan Pharmaceuticals (TTNP) United States $0.012B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00